{"preliminary_commentary":{"by_channel":{"x_thread":6},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this."},"free_build":{"available":false},"commentary_summary":null,"drugs_tested":[["nivolumab","radiation therapy"]],"indication":"locally advanced urothelial carcinoma of the bladder","name":"RACE IT","nct_id":"NCT03529890","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=race-it-nct03529890. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":"RACE IT","arms":[{"description":"Single arm treatment with Nivolumab during a neoadjuvant radiation therapy of the pelvis before radical cystectomy with standardized pelvic lymphadenectomy","label":"Radio-Immunotherapy before cystectomy","type":"EXPERIMENTAL"}],"collaborators":["Bristol-Myers Squibb"],"completion_date":{"date":"2023-08","type":"ESTIMATED"},"conditions":["Urinary Bladder Cancer"],"enrollment":{"count":33,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"Nivolumab","otherNames":["Opdivo"],"type":"DRUG"},{"name":"Radiation therapy of the pelvis","otherNames":[],"type":"RADIATION"},{"name":"Radical cystectomy with standardized pelvic lymphadenectomy","otherNames":[],"type":"PROCEDURE"}],"last_update":"2022-10-20","lead_sponsor":"Technical University of Munich","official_title":"A Prospective, Single Arm, Multicenter, Phase II-Trial to Assess Safety and Efficacy of Preoperative RAdiation Therapy Before Radical CystEctomy Combined With ImmunoTherapy in Locally Advanced Urothelial Carcinoma of the Bladder","overall_status":"UNKNOWN","phases":["PHASE2"],"primary_completion_date":{"date":"2022-04-14","type":"ACTUAL"},"primary_outcomes":[{"measure":"Rate of patients with completed Treatment","timeFrame":"end of week 15"}],"references":[{"citation":"Schmid SC, Koll FJ, Rodel C, Maisch P, Sauter A, Beckert F, Seitz A, Kubler H, Flentje M, Chun F, Combs SE, Schiller K, Gschwend JE, Retz M. Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer - study protocol of a prospective, single arm, multicenter phase II trial (RACE IT). BMC Cancer. 2020 Jan 3;20(1):8. doi: 10.1186/s12885-019-6503-6.","pmid":"31900121","type":"DERIVED"}],"start_date":{"date":"2019-02-04","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder","url":"https://clinicaltrials.gov/study/NCT03529890"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.1","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/race-it-nct03529890"}